Charlotte's Web Reports 2021 Fourth Quarter and Year-End Financial Results
Charlotte's Web reported a slight 1% increase in 2021 revenue to $96.1 million. The Adjusted EBITDA loss improved by $5 million to ($18.6 million). The company ended 2021 with $19.5 million in cash. DTC e-commerce revenue fell 2.3% to $62.3 million, while B2B revenue grew 7.5% to $33.8 million. A net loss of $137.7 million for the year included $107.7 million in non-cash impairments. Charlotte's Web expands market presence amid ongoing regulatory actions, with new product innovations and initiatives for international growth.
- 2021 revenue increased by 1% to $96.1 million.
- B2B revenue grew by 7.5% to $33.8 million, enhancing market share.
- Net loss increased to $137.7 million, including $107.7 million in non-cash impairments.
- DTC revenue decreased by 2.3% to $62.3 million.
- 2021 Revenue grew
1% to$96.1M - Adjusted EBITDA1 Loss improved
$5M to ($18.6M ) $19.5M cash at December 31, 2021
DENVER, March 24, 2022 /PRNewswire/ - (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the fourth quarter and year ended December 31, 2021.
Effective January 4, 2022, Charlotte's Web became a registrant of the U.S. Securities and Exchange Commission and subject to U.S. reporting requirements including the Company's financial statements and financial data to be presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). Amounts are presented in United States' dollars, unless otherwise indicated.
"At the beginning of 2022 we took organizational actions, better aligned leadership and employees with shareholder interests, and simplified our business for focus, speed, and executional excellence. Our organization is fully engaged and we intend to grow our business," said Jacques Tortoroli, Chief Executive Officer of Charlotte's Web. "We have substantially completed our multi-year investment in our production capacity to effectively service a sophisticated mass retail channel when federal regulations are set for the CBD wellness category in the U.S. In the interim, regardless of regulatory actions, we are focused on developing sustainable revenue growth with our current customers and through new customer acquisitions, and new channels, as well as selective innovation in new products, and international market expansion."
2021 Revenue Growth
For the twelve-month period ended December 31, 2021, net revenue grew
Direct-to-consumer ("DTC") e-commerce revenue decreased
2021 Operations
Gross profit was
____________________ |
* Certain metrics, including those expressed on an adjusted basis, are non-GAAP measures, see "Non-GAAP Measures" below for additional information and a reconciliation to GAAP for all Non-GAAP metrics. |
2021 Milestones
Charlotte's Web continues to support federal and state legislative actions to help advance a comprehensive U.S. CBD regulatory framework, including the successful passing of state Assembly Bill 45 legalizing hemp CBD in California, and expanded bi-partisan sponsorship of Federal Bill H.R. 841. The Company also completed a clinical study reaffirming the liver health safety of Charlotte's Web™ hemp derived CBD extracts and shared the quantitative data study results with the U.S. Food and Drug Administration.
Charlotte's Web achieved USDA organic certification on select products and secured three new U.S. Patents for proprietary hemp cultivars, bringing its total to five. To secure future optionality to enter the U.S. cannabis wellness category, Charlotte's Web purchased an option agreement to acquire Stanley Brothers cannabis business pending US federal legalization of cannabis.
International expansion initiatives progress in Canada where the Company completed the first international harvest of Charlotte's Web's proprietary patented hemp cultivars, with product planned for late 2022 availability. In the U.K., the Company's applications were accepted and being processed for Novel Foods authorization. Charlotte's Web recently appointed Savage Cabbage as the Company's exclusive distributor in the U.K. The founder and CEO of Savage Cabbage, Jade Proudman, was also named the Company's Global Brand Ambassador. In Israel Charlotte's Web is preparing for product availability through its exclusive distribution partnership with Israel-based Intercure, pending Ministry of Health legalization of CBD.
"Internationally, our asset-light approach through partnerships provides efficient and cost-effective global expansion routes to market," said Wes Booysen, Chief Financial Officer of Charlotte's Web. "Additionally, as part of our recent reorganization, we believe we have right-sized our operating expenses to our current revenue."
Balance Sheet and Cash Flow
Total cash use for 2021 was
Q4-2021 Financial Review
Fourth quarter impairment of intangible assets, long-lived assets and goodwill
The Company recognized impairments of
The following table sets forth selected financial information for the periods indicated.
Three Months Ended December 31, | ||||||
U.S. $ millions, except per share data | 2021 | 2020 | ||||
Revenue | $ | 24.8 | $ | 26.9 | ||
Cost of goods sold | 20.6 | 16.4 | ||||
Gross profit | 4.2 | 10.6 | ||||
Selling, general and administrative expenses | 24.4 | 23.3 | ||||
Goodwill and asset impairments | 98.0 | — | ||||
Operating loss | (118.2) | (12.7) | ||||
Other income, net | (0.3) | 0.3 | ||||
Change in fair value of financial instruments and other | 0.3 | (2.0) | ||||
Income tax (expense) benefit | (0.2) | 0.1 | ||||
Net loss and comprehensive loss | $ | (118.2) | $ | (14.3) | ||
Net loss per common share, basic and diluted | $ | (0.86) | $ | (0.10) | ||
Consolidated net revenue for the fourth quarter ended December 31, 2021 was
Fourth quarter DTC net revenue was
Fourth quarter B2B revenue growth was flat year-over-year at
Three Months Ended | |||||||||
December 31, | % Increase | ||||||||
2021 | 2020 | ||||||||
Total revenue - U.S. $ millions | $ | 24.8 | $ | 26.9 | (7.8) | % | |||
Direct-to-consumer ("DTC") net revenue | $ | 15.3 | $ | 17.4 | (12.1) | % | |||
Business-to-business ("B2B") net revenue | $ | 9.5 | $ | 9.5 | — | % | |||
Higher retail volumes and brand leadership produced market share gains at B2B retail across core retail channels. Charlotte's Web holds the number one market share position across major retail channels including total U.S. F/D/M, total U.S. natural specialty retail, and e-commerce, based on market share data from leading third-party analysts such as Nielsen, SPINS, and Brightfield Group, respectively.
Gross profit of
Total SG&A expenses increased
Net loss was
Consolidated Financial Statements and Management's Discussion and Analysis
The Company's audited consolidated financial statements and accompanying notes for the year ended December 31, 2021 and 2020 and related management's discussion and analysis of financial condition and results of operations ("MD&A") are reported in the Company's 10K filing on the Securities and Exchange Commission website at www.sec.gov and on SEDAR at www.sedar.com, and will be available on the Investor Relations section of the Company's website at https://investors.charlottesweb.com.
Conference Call
Management will host a conference call to discuss the Company's 2021 fourth quarter and year-end results at 8:30 a.m. ET on March 24, 2022. To participate in the call, please dial 1-416-764-8659 approximately 10 minutes before the conference call. A recording of the call will be available through March 31, 2022. To listen to the rebroadcast please dial 1-416-764-8677 and provide conference ID 231528. A webcast of the call can be accessed through the investor relations section of the Charlotte's Web website.
About Charlotte's Web Holdings, Inc.
Charlotte's Web Holdings, Inc., a Certified B Corporation headquartered in Denver, is the market leader in innovative hemp extract wellness products under a family of brands which includes Charlotte's Web™, CBD Medic™, CBD Clinic™, and Harmony Hemp™. Charlotte's Web branded premium quality products start with proprietary hemp genetics that are 100-percent American farm grown and manufactured into hemp extracts containing naturally occurring phytocannabinoids including cannabidiol ("CBD"), CBC, CBG, terpenes, flavonoids, and other beneficial hemp compounds. The Company's CW Labs R&D division, advances hemp science at two centers of excellence in Louisville, Colorado, and the Hauptmann Woodward Research Institute at the University at Buffalo, part of the State University of New York (SUNY) network. Charlotte's Web product categories include full-spectrum hemp CBD oil tinctures (liquid products), CBD gummies (sleep, stress, exercise recovery), CBD capsules, CBD topical creams and lotions, as well as CBD pet products for dogs. Through its vertically integrated business model, Charlotte's Web maintains stringent control over product quality and consistency. Charlotte's Web products are distributed to more than 15,000 retail, over 8,000 health care practitioners, and online through the Company's website at www.CharlottesWeb.com.
Charlotte's Web was founded by the seven Stanley Brothers with a mission to unleash the healing powers of botanicals through compassion and science, benefiting the planet and all who live upon it. Charlotte's Web is a socially and environmentally conscious company and is committed to using business as a force for good and a catalyst for innovation. The Company weighs sound business decisions with consideration for how its efforts affect employees, customers, the environment, and diverse communities. The rate the Company pays for agricultural products reflects a fair and sustainable rate driving higher quality yield, encouraging regenerative farming practices, and supporting U.S. farming communities. Management believes that its socially oriented and environmentally responsible actions have a positive impact on its customers, suppliers, employees and stakeholders. Charlotte's Web donates a portion of its pre-tax earnings to charitable organizations.
Shares of Charlotte's Web trade on the Toronto Stock Exchange (TSX) under the symbol "CWEB" and are quoted in U.S. Dollars in the United States on the OTCQX under the symbol "CWBHF". As of March 22, 2021, Charlotte's Web had 145,110,106 Common Shares outstanding.
Forward-Looking Information
In the interest of providing the shareholders and potential investors of Charlotte's Web Holdings, Inc. with information about the Company, certain information provided herein constitutes forward-looking statements or information (collectively, "forward-looking statements") within the meaning of applicable securities laws. Forward-looking statements are typically identified by words such as "may", "will", "should", "could", "anticipate", "expect", "project", "estimate", "forecast", "plan", "intend", "target", "believe" and similar words suggesting future outcomes or statements regarding an outlook. Although these forward-looking statements are based on assumptions the Company considers to be reasonable based on the information available on the date such statements are made, such statements are not guarantees of future performance and readers are cautioned against placing undue reliance on forward-looking statements. By their nature, these statements involve a variety of assumptions, known and unknown risks and uncertainties, and other factors which may cause actual results, levels of activity, and achievements to differ materially from those expressed or implied by such statements. The forward-looking statements contained in this press release are based on certain assumptions and analysis by management of the Company in light of its experience and perception of historical trends, current conditions and expected future development and other factors that it believes are appropriate.
Specifically, this press release contains forward-looking statements relating to, but not limited to: activities relating to, and sponsorship of, legislation to advance regulatory framework; future optionality to enter the U.S. cannabis wellness category through purchase option agreement with Stanley Brothers; anticipated consumer trends and corresponding product innovation; anticipated future financial results; international expansion activities and strategy, including Israel product launch, harvest and planned product sales in Canada, and expansion in UK and EU; sales volume, product, channel and international expansion plans; growth of the Company's market share position; collection of a near-term IRS tax refund; that the reorganization right sized our operating expenses to our revenue; the impact of certain activities on the Company's business and financial condition; suggested regulatory developments; and the Company's anticipated trajectory, long-term growth expectations and shareholder value creation.
The material factors and assumptions used to develop the forward-looking statements herein include, but are not limited to, the following: the impact of the COVID-19 pandemic; the regulatory climate in which the Company currently operates and may in the future operate; successful sales of the Company's products; the success of sales and marketing activities; there will be no significant delays in the development and commercialization of the Company's products, including in relation to supply chain disruptions; outcomes from R&D activities; ability for the Company to leverage R&D and brand recognition for product sales; the Company's ability to deal with adverse growing conditions (due to pests, disease, fungus, climate or other factors) in a timely and cost-effective manner; there will be no significant reduction in the availability of qualified and cost-effective human resources; new products will continue to be added to the Company's portfolio; demand for the Company's products will grow in the foreseeable future; there will be no significant barriers to the acceptance of the Company's products in the market, including in international markets; the Company will be able to maintain compliance with applicable contractual and regulatory obligations and requirements; there will be adequate liquidity available to the Company to carry out its operations and business plans; the Company will have sufficient capital to pursue its sales volume, product, channel and international expansion; and products do not develop that would render the Company's current and future product offerings undesirable and the Company is otherwise able to minimize the impact of competition and keep pace with changing consumer preferences.
The Company's forward-looking statements are subject to risks and uncertainties pertaining to, among other things, the adverse impact of the COVID-19 pandemic to the Company's operations, supply chain, distribution chain, and to the broader market for the Company's products; revenue fluctuations; nature of government regulations (both domestic and foreign); economic conditions; loss of key customers; retention and availability of executive talent; competing products; common share price volatility; loss of proprietary information; product acceptance; internet and system infrastructure functionality; information technology security; available capital to fund operations and business plans; crop risk; international and political considerations; regulatory changes; and including but not limited to those risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ending December 31, 2021 available on www.sec.gov and www.sedar.com, and other risk factors contained in other filings with the Securities and Exchange Commission available on www.sec.gov and filings with Canadian securities regulatory authorities available on www.sedar.com. The impact of any one risk, uncertainty, or factor on a particular forward-looking statement is not determinable with certainty as these are interdependent, and the Company's future course of action depends on management's assessment of all information available at the relevant time.
Except as required by applicable law, the Company assumes no obligation to publicly update or revise any forward-looking statements made, whether as a result of new information, future events, or otherwise. All forward-looking statements, whether written or oral, attributable to the Company or persons acting on the Company's behalf, are expressly qualified in their entirety by these cautionary statements.
CHARLOTTE'S WEB HOLDINGS, INC. | |||||
December 31, | |||||
2021 | 2020 | ||||
ASSETS | |||||
Current assets: | |||||
Cash and cash equivalents | $ | 19,494 | $ | 52,803 | |
Accounts receivable, net | 4,882 | 4,793 | |||
Notes receivable - current | 495 | 2,757 | |||
Inventories, net | 52,077 | 63,157 | |||
Prepaid expenses and other current assets | 8,095 | 8,845 | |||
Income taxes receivable | 10,764 | 11,440 | |||
Total current assets | 95,807 | 143,795 | |||
Property and equipment, net | 36,085 | 39,363 | |||
Operating lease right-of-use assets, net | 20,679 | 21,037 | |||
Intangible assets, net | 2,843 | 25,376 | |||
Goodwill | — | 76,039 | |||
Stanley Brothers USA Holdings purchase option | 13,000 | — | |||
Notes receivable - noncurrent | 1,037 | — | |||
Other long-term assets | 2,062 | 5,177 | |||
Total assets | $ | 171,513 | $ | 310,787 | |
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||
Current liabilities: | |||||
Accounts payable | $ | 5,049 | $ | 4,891 | |
Accrued and other current liabilities | 9,570 | 12,763 | |||
Cultivation liabilities – current | 3,448 | 9,304 | |||
Lease obligations – current | 2,103 | 1,916 | |||
Total current liabilities | 20,170 | 28,874 | |||
Cultivation liabilities – noncurrent | 385 | 2,513 | |||
Lease obligations – noncurrent | 20,500 | 20,567 | |||
Warrant and other long-term liabilities | 12 | 4,591 | |||
Total liabilities | 41,067 | 56,545 | |||
Commitments and contingencies | |||||
Shareholders' equity: | |||||
Common shares, nil par value; unlimited shares authorized as of December 31, 2021 and 2020, respectively; 144,659,964 and 107,060,237 shares issued and outstanding as of December 31, 2021 and 2020 | 1 | 1 | |||
Proportionate voting shares, nil par value; nil shares authorized as of December 31, 2021 and unlimited shares authorized as of December 31, 2020, respectively; nil and 81,177 outstanding as of December 31, 2021 and December 31, 2020, respectively | — | — | |||
Additional paid-in capital | 319,059 | 305,133 | |||
Accumulated deficit | (188,614) | (50,892) | |||
Total shareholders' equity | 130,446 | 254,242 | |||
Total liabilities and shareholders' equity | $ | 171,513 | $ | 310,787 | |
CHARLOTTE'S WEB HOLDINGS, INC. | |||||
Year Ended December 31, | |||||
2021 | 2020 | ||||
Revenue | $ | 96,092 | $ | 95,226 | |
Cost of goods sold | 47,507 | 42,937 | |||
Gross profit | 48,585 | 52,289 | |||
Selling, general and administrative expenses | 97,641 | 103,631 | |||
Goodwill and asset impairments | 98,003 | — | |||
Operating loss | (147,059) | (51,342) | |||
Other income, net | 51 | 1,330 | |||
Change in fair value of financial instruments and other | 9,429 | 11,317 | |||
Loss before provision for income taxes | $ | (137,579) | $ | (38,695) | |
Income tax (expense) benefit | (143) | 8,014 | |||
Net loss and comprehensive loss | $ | (137,722) | $ | (30,681) | |
Net loss per common share, basic and diluted | $ | (0.98) | $ | (0.25) | |
Weighted-average shares used in computing net loss per share, basic and diluted | 140,769,247 | 125,012,249 | |||
CHARLOTTE'S WEB HOLDINGS, INC. | |||||||||||||||
Proportionate | Common Shares | Additional |
Accumulated |
Total | |||||||||||
Shares | Shares | Amount | |||||||||||||
Balance—December 31, 2019 | 95,342 | 67,418,174 | $ | 1 | $ | 144,206 | $ | (20,211) | $ | 123,996 | |||||
Exercise of stock options | — | 3,987,035 | — | 2,467 | — | 2,467 | |||||||||
Conversion to common shares | (16,140) | 6,455,826 | — | — | — | — | |||||||||
Withholding of common shares upon vesting of restricted share units | — | 32,801 | — | (19) | — | (19) | |||||||||
Share-based compensation | — | — | — | 3,149 | — | 3,149 | |||||||||
Harmony Hemp contingent equity compensation | — | 114,696 | — | 1,177 | — | 1,177 | |||||||||
2020 Share offering, net of warrants and issuance costs | — | 11,500,000 | — | 44,591 | — | 44,591 | |||||||||
Abacus acquisition | 1,975 | 17,551,705 | — | 109,562 | — | 109,562 | |||||||||
Net loss and comprehensive loss | — | — | — | — | (30,681) | (30,681) | |||||||||
Balance—December 31, 2020 | 81,177 | 107,060,237 | $ | 1 | $ | 305,133 | $ | (50,892) | $ | 254,242 | |||||
Exercise of stock options | — | 8,261 | $ | — | $ | 30 | $ | — | $ | 30 | |||||
Conversion to common shares | (81,177) | 32,471,060 | — | — | — | — | |||||||||
Exercise of warrants | — | 98,788 | — | 441 | — | 441 | |||||||||
Withholding of common shares upon vesting of restricted share units | — | 182,727 | — | (146) | — | (146) | |||||||||
Harmony Hemp contingent equity compensation | — | 338,091 | — | 1,460 | — | 1,460 | |||||||||
ATM Program, net of share issuance costs | — | 4,500,800 | — | 8,118 | — | 8,118 | |||||||||
Share-based compensation | — | — | — | 4,023 | — | 4,023 | |||||||||
Net loss and comprehensive loss | — | — | — | — | (137,722) | (137,722) | |||||||||
Balance—December 31, 2021 | — | 144,659,964 | $ | 1 | $ | 319,059 | $ | (188,614) | $ | 130,446 | |||||
CHARLOTTE'S WEB HOLDINGS, INC. | |||||
Year Ended December 31, | |||||
2021 | 2020 | ||||
Cash flows from operating activities: | |||||
Net loss and comprehensive loss | $ | (137,722) | $ | (30,681) | |
Adjustments to reconcile net loss and comprehensive loss to net cash used in operating activities: | |||||
Depreciation and amortization | 11,025 | 6,847 | |||
Goodwill and asset impairments | 98,003 | — | |||
Change in fair value of financial instruments | (9,305) | (11,167) | |||
Allowance for credit losses | 1,509 | 834 | |||
Inventory provision | 9,729 | 8,025 | |||
Share-based compensation | 5,483 | 4,326 | |||
Loss (gain) on disposal of assets | 390 | (5) | |||
Changes in operating assets and liabilities: | |||||
Accounts receivable, net | (948) | 1,470 | |||
Inventories | 1,023 | (1,782) | |||
Prepaid expenses and other current assets | 694 | (2,867) | |||
Operating lease right-of-use assets and lease obligations | 138 | 569 | |||
Accounts payable, accrued and other liabilities | (2,911) | (8,075) | |||
Income taxes | 676 | (8,133) | |||
Cultivation liabilities | (7,166) | (11,289) | |||
Other operating assets and liabilities, net | (177) | (101) | |||
Net cash used in operating activities | (29,559) | (52,029) | |||
Cash flows from investing activities: | |||||
Acquisition of business, net of cash acquired | — | 11,181 | |||
Purchases of property and equipment and intangible assets | (4,918) | (28,257) | |||
Proceeds from sale of assets | 13 | 91 | |||
Issuance of notes receivable, net of collections | 510 | (1,275) | |||
Investment in Stanley Brothers USA Holdings purchase option | (8,000) | — | — | ||
Other investing activities | 606 | (897) | |||
Net cash used in investing activities | (11,789) | (19,157) | |||
Cash flows from financing activities: | |||||
Proceeds from public offerings, net of issuance costs | 8,257 | 53,797 | |||
Proceeds from stock option exercises | 30 | 2,467 | |||
Other financing activities | (248) | (828) | |||
Net cash provided by financing activities | 8,039 | 55,436 | |||
Net decrease in cash and cash equivalents | (33,309) | (15,750) | |||
Cash and cash equivalents —beginning of year | 52,803 | 68,553 | |||
Cash and cash equivalents —end of year | $ | 19,494 | $ | 52,803 | |
Non-cash activities: | |||||
Equity instruments issued in business combinations | $ | — | $ | 109,562 | |
Non-cash purchases of property and equipment | (2,500) | (1,291) | |||
Non-cash inventory provision | (543) | (2,073) | |||
(1) Non-GAAP Measures
Adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") and gross profit excluding inventory provision are not recognized performance measures under U.S. GAAP. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. Adjusted EBITDA does not have a standardized meaning prescribed under U.S. GAAP and therefore may not be comparable to similar measures presented by other issuers. The term EBITDA consists of net loss and excludes interest, taxes, depreciation and amortization. Adjusted EBITDA also excludes share-based compensation, impairment of assets, transaction costs, legal settlement costs, restructuring charges, and adjustments for fair value. Adjusted EBITDA is included as a supplemental disclosure because management of the Company believes that such measurement provides a more meaningful assessment of the Company's operations on a continuing basis by eliminating certain non-cash charges and charges or gains that are infrequent. The most directly comparable measure to Adjusted EBITDA calculated in accordance with U.S. GAAP is net loss. See "Adjusted EBITDA" below for a reconciliation of Adjusted EBITDA to net loss, the most directly comparable U.S. GAAP measure. Gross profit, excluding inventory provisions, is gross profit as stated in the Company's Consolidated Statements of Operations and Comprehensive Loss adjusted to exclude the non-cash inventory provisions of
Three months ended | Twelve months ended | |||||||||
December 31, | December 31, | |||||||||
U.S. $ millions | 2021 | 2020 | 2021 | 2020 | ||||||
Net loss and comprehensive loss | $ | (118.2) | $ | (14.3) | $ | (137.7) | $ | (30.7) | ||
Depreciation of property and equipment and amortization of intangibles | 2.8 | 2.2 | 11.0 | 6.8 | ||||||
Financing costs | 0.1 | (0.1) | 0.1 | 0.1 | ||||||
Interest income | — | — | — | (0.1) | ||||||
Income tax | 0.1 | (0.1) | 0.1 | (8.0) | ||||||
EBITDA | $ | (115.2) | $ | (12.3) | (126.5) | (31.9) | ||||
Mark-to-market financial instruments | (0.3) | 2.0 | (9.4) | (11.3) | ||||||
Share-based compensation | 1.4 | 1.0 | 5.5 | 4.3 | ||||||
Impairment of assets | 107.6 | 5.8 | 107.7 | 8.0 | ||||||
SEC registration and other transaction costs | 1.0 | 0.2 | 1.9 | 5.9 | ||||||
Restructuring charges | 1.0 | 0.2 | 2.2 | 1.4 | ||||||
Adjusted EBITDA(1) | $ | (4.5) | $ | (3.1) | (18.6) | (23.6) | ||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/charlottes-web-reports-2021-fourth-quarter-and-year-end-financial-results-301509824.html
SOURCE Charlotte's Web Holdings, Inc.
